FORMA’s FASN Inhibitor FT-4101 Significantly Reduced Hepatic De Novo Lipogenesis in Healthy Adult Subjects

Saved in:
Bibliographic Details
Published inBusiness Wire
Format Newsletter
LanguageEnglish
Published New York Business Wire 08.11.2019
Subjects
Blood diseases
Drug dosages
Enzymes
Fatty acids
Inflammation
Liver
Patients
Statistical significance
WATERTOWN, Mass
Online AccessGet full text

Cover

More Information
Description not available.